Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07123480 · ClinicalTrials.gov registry record · NA
The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance
A NA study of Heart Failure and Cardiac Rehabilitation, sponsored by Baystate Medical Center.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07123480: Active NA study of Heart Failure and Cardiac Rehabilitation, sponsored by Baystate Medical Center.
NCT07123480 is a NA study of Heart Failure and Cardiac Rehabilitation that is active but no longer recruiting, run by Baystate Medical Center. The registered enrollment target is 160 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07123480, a NA study of Heart Failure and Cardiac Rehabilitation, is active but no longer recruiting, sponsored by Baystate Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiac Rehabilitation is a lifestyle and exercise program for patients with heart disease. Cardiac Rehabilitation is strongly recommended in guidelines, but only 30% of eligible patients attend. New strategies are needed to help more patients attend cardiac rehabilitation. In this study, the investigators will see if using an $50 incentive, case management, text messages, and physical activity coaching combined into a single intervention will help more patients attend cardiac rehabilitation. In preparation for a larger trial, patients will also be randomly assigned to four different ways of seeking their permission to be in a research study. The investigators will see if these approaches affect how many people participate in the research project. The two main goals of this study is to understand: 1. If the consent approach type impacts participation rates in the research study 2. If the multi-component intervention (case management, financial incentives, text messages, and physical activity coaching) improves cardiac rehabilitation participation within 3 months.
Primary Outcome
The proportion of patients (%) participating in the clinical trial.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care Group
- BEHAVIORAL More Support and Tools
Study Locations (1)
Massachusetts
- Baystate Medical Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT07123480 still lists
NCT07123480 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower).
The record links to 7 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Group is the first listed.
NCT07123480 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07123480 about?
NCT07123480 is a clinical study titled "The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance". Cardiac Rehabilitation is a lifestyle and exercise program for patients with heart disease. Cardiac Rehabilitation is strongly recommended in guidelines, but only 30% of eligible patients attend. New strategies are needed to help more patients attend cardiac rehabilitation. In this study, the inves...
What is the current status of trial NCT07123480?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-07-16. Estimated completion is 2026-06-30.
What conditions does trial NCT07123480 study?
This clinical trial studies the following conditions: Heart Failure, Cardiac Rehabilitation, Aortic Valve Replacement, Ethics, Percutaneous Coronary Intervention (PCI).
What interventions are being tested in trial NCT07123480?
The interventions under investigation include: Usual Care Group (BEHAVIORAL), More Support and Tools (BEHAVIORAL).
Who is sponsoring clinical trial NCT07123480?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07123480 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07123480's enrollment target sits among peer trials
160 185th of 397 higher than 212 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI